Literature DB >> 26558819

Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.

Kazuomi Kario1, Deepak L Bhatt2, Sandeep Brar2, Sidney A Cohen2, Martin Fahy2, George L Bakris2.   

Abstract

UNLABELLED: High nighttime and early morning blood pressure (BP) have been associated with greater risk for cardiovascular events than high clinic or daytime BP. BP is typically highest in the rising hours, when morning activities typically begin. We examined the effect of renal denervation on morning (6:00-8:59 AM), daytime (9:00 AM-8:59 PM), and nighttime (1:00-5:59 AM) ambulatory BP. Patient data from 2 prospective, randomized controlled trials of patients with treatment-resistant, uncontrolled hypertension, one conducted in a US population (Renal Denervation in Patients With Uncontrolled Hypertension [SYMPLICITY HTN-3]) and the other in a Japanese population (SYMPLICITY HTN-Japan [HTN-Japan]), were analyzed. Patients in SYMPLICITY HTN-3 and HTN-Japan were prescribed a similar number of baseline antihypertensive medications (5.2±1.4 versus 4.9±1.6, P=0.28), but the classes prescribed and changes in prescription varied by study. Among patients treated with renal denervation, although the number of ablation treatments were similar in both studies (11.2±2.8 versus 11.5±1.9, P=0.55), patients in SYMPLICITY HTN-3 were less likely to receive at least 1 four-quadrant ablation treatment (25% versus 82%, P<0.001). In SYMPLICITY HTN-3, compared with controls (n=159), patients treated with renal denervation (n=325) experienced a significantly greater change in morning (-7.3±19.8 mm Hg, P<0.001) and nighttime (-6.1±18.2 versus -1.6±19.7 mm Hg, P=0.02) but not daytime systolic BP (-7.2±16.2 versus -6.4±18.6 mm Hg, P=0.67). This same trend was observed in the pooled analysis with HTN-Japan. Reduction of BP during these high-risk periods might provide cardiovascular protection in drug-resistant hypertensive patients, although this will need to be proved in future randomized trials. CLINICAL TRIAL REGISTRATION: URL: www.clinicaltrials.gov; Unique identifiers: NCT01418261 (SYMPLICITY HTN-3) and NCT01644604 (HTN-Japan).
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  SYMPLICITY; ambulatory blood pressure monitoring; blood pressure; denervation; hypertension

Mesh:

Substances:

Year:  2015        PMID: 26558819     DOI: 10.1161/HYPERTENSIONAHA.115.06260

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.

Authors:  Franco Rabbia; Elisa Testa; Chiara Fulcheri; Elena Berra; Silvia Di Monaco; Michele Covella; Marco Pappaccogli; Silvia Monticone; Renato Rosiello; Denis Rossato; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-03

Review 2.  Renal denervation for resistant hypertension.

Authors:  Giuseppe Coppolino; Anna Pisano; Laura Rivoli; Davide Bolignano
Journal:  Cochrane Database Syst Rev       Date:  2017-02-21

Review 3.  Renal denervation for resistant hypertension.

Authors:  Anna Pisano; Luigi Francesco Iannone; Antonio Leo; Emilio Russo; Giuseppe Coppolino; Davide Bolignano
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

4.  Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network.

Authors:  Kazuomi Kario; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Yook-Chin Chia; Romeo Divinagracia; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Yuqing Zhang; Sungha Park; Huynh Van Minh; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09       Impact factor: 3.738

5.  The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.

Authors:  Marguerite R Irvin; John N Booth; Mario Sims; Adam P Bress; Marwah Abdalla; Daichi Shimbo; David A Calhoun; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-13       Impact factor: 3.738

6.  Polysomnography-derived sleep parameters as a determinant of nocturnal blood pressure profile in patients with obstructive sleep apnea.

Authors:  Mitsuo Kuwabara; Naoko Tomitani; Toshikazu Shiga; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-30       Impact factor: 3.738

7.  Novel Triggered Nocturnal Blood Pressure Monitoring for Sleep Apnea Syndrome: Distribution and Reproducibility of Hypoxia-Triggered Nocturnal Blood Pressure Measurements.

Authors:  Mitsuo Kuwabara; Haruna Hamasaki; Naoko Tomitani; Toshikazu Shiga; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-14       Impact factor: 3.738

Review 8.  Systemic Hemodynamic Atherothrombotic Syndrome and Resonance Hypothesis of Blood Pressure Variability: Triggering Cardiovascular Events.

Authors:  Kazuomi Kario
Journal:  Korean Circ J       Date:  2016-07-21       Impact factor: 3.243

9.  Renal denervation: are we at a crossroads?

Authors:  M Voskuil
Journal:  Neth Heart J       Date:  2016-07       Impact factor: 2.380

10.  Acupuncture Attenuates Renal Sympathetic Activity and Blood Pressure via Beta-Adrenergic Receptors in Spontaneously Hypertensive Rats.

Authors:  Jing-Wen Yang; Yang Ye; Xue-Rui Wang; Fang Li; Ling-Yong Xiao; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Neural Plast       Date:  2017-02-08       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.